Birzeit Pharmaceutical Company

A seven to nine-member Board, elected by shareholders through secret vote, manages the Company. Board terms are limited to two years, ending with new elections.

The Chairman and the members of the Board of Directors fulfill their responsibilities by conducting regular meetings to monitor the company's progress in its operations through various committees.

The management includes a variety of leaders like Talal and Firas Nasereddin, with expertise across finance, chemistry, engineering, pharmacy, Business management and more, driving company operations.

Birzeit Pharmaceuticals emphasizes transparency and integrity, mandating adherence to a Code of Ethics for all management and staff, ensuring ethical conduct in all operations.

BPC's Board Of Directors hold a minimum of six meetings annually. All shareholders are personally invited to attend the Ordinary General Assembly Meeting, and this invitation includes the meeting schedule. The date of the general assembly is publicly announced in official newspapers at least two weeks prior to the meeting date.